Published in Neurol Sci on June 01, 2010
Adiponectin and leptin levels in migraineurs in the Atherosclerosis Risk in Communities Study. Neurology (2014) 2.66
Migraine and obesity: epidemiology, possible mechanisms and the potential role of weight loss treatment. Obes Rev (2011) 1.24
Migraine and periodic limb movement disorders in sleep in children: a preliminary case-control study. J Headache Pain (2013) 0.99
Osmophobia in allodynic migraineurs: cause or consequence of central sensitization? Neurol Sci (2015) 0.99
Is the brain of migraineurs "different" even in dreams? Neurol Sci (2014) 0.98
Studies on the pathophysiology and genetic basis of migraine. Curr Genomics (2013) 0.94
Prevalence and risk of migraine headaches in adult fragile X premutation carriers. Clin Genet (2013) 0.93
Biochemistry of primary headaches: role of tyrosine and tryptophan metabolism. Neurol Sci (2015) 0.90
Migraine with aura: conventional and non-conventional treatments. Neurol Sci (2011) 0.87
Are depression, anxiety and poor mental health risk factors for knee pain? A systematic review. BMC Musculoskelet Disord (2014) 0.83
Mass spectrometry imaging of amino neurotransmitters: a comparison of derivatization methods and application in mouse brain tissue. Metabolomics (2016) 0.82
Pre-treatment with new kynurenic acid amide dose-dependently prevents the nitroglycerine-induced neuronal activation and sensitization in cervical part of trigemino-cervical complex. J Neural Transm (Vienna) (2014) 0.81
The biology of the glutamatergic system and potential role in migraine. Int J Biomed Sci (2013) 0.80
Migraine predicts physical and pain symptoms among psychiatric outpatients. J Headache Pain (2013) 0.80
New directions in migraine. BMC Med (2011) 0.80
Is migraine a risk factor for the occurrence of eating disorders? Prevalence and biochemical evidences. Neurol Sci (2012) 0.80
Pharmacoinformatics elucidation of potential drug targets against migraine to target ion channel protein KCNK18. Drug Des Devel Ther (2014) 0.78
Polymorphisms in migraine-associated gene, atp1a2, and ischemic stroke risk in a biracial population: the genetics of early onset stroke study. Springerplus (2013) 0.76
A splice variant in the ACSL5 gene relates migraine with fatty acid activation in mitochondria. Eur J Hum Genet (2016) 0.75
Increased migraine risk in osteoporosis patients: a nationwide population-based study. Springerplus (2016) 0.75
Modulatory Effects of Dopamine D2 Receptors on Spreading Depression in Rat Somatosensory Neocortex. Basic Clin Neurosci (2014) 0.75
Ventricular tachycardia during basilar-type migraine attack. Ther Adv Neurol Disord (2013) 0.75
Intravenous caffeine citrate vs. magnesium sulfate for reducing pain in patients with acute migraine headache; a prospective quasi-experimental study. Korean J Pain (2017) 0.75
Ten-year mortality from cardiovascular disease in relation to cholesterol level among men with and without preexisting cardiovascular disease. N Engl J Med (1990) 3.29
Mast cells express a peripheral cannabinoid receptor with differential sensitivity to anandamide and palmitoylethanolamide. Proc Natl Acad Sci U S A (1995) 2.33
Temperature monitoring during radiofrequency catheter ablation of accessory pathways. Circulation (1992) 2.31
Radiofrequency catheter ablation of accessory atrioventricular connections in 250 patients. Abbreviated therapeutic approach to Wolff-Parkinson-White syndrome. Circulation (1992) 2.00
Electrogram criteria for identification of appropriate target sites for radiofrequency catheter ablation of accessory atrioventricular connections. Circulation (1992) 1.88
The ALIAmide palmitoylethanolamide and cannabinoids, but not anandamide, are protective in a delayed postglutamate paradigm of excitotoxic death in cerebellar granule neurons. Proc Natl Acad Sci U S A (1996) 1.84
Nerve growth factor: from neurotrophin to neurokine. Trends Neurosci (1996) 1.70
Is ilioinguinal/iliohypogastric nerve block always totally safe in children? Paediatr Anaesth (2003) 1.66
N-(2-hydroxyethyl)hexadecanamide is orally active in reducing edema formation and inflammatory hyperalgesia by down-modulating mast cell activation. Eur J Pharmacol (1996) 1.61
Biventricular pacing using two pacemakers and the triggered VVT mode. Pacing Clin Electrophysiol (2001) 1.55
In vitro generation of dendritic cells from human blood monocytes in experimental conditions compatible for in vivo cell therapy. J Hematother Stem Cell Res (2000) 1.43
Seasonal and mood independence of low basal prolactin secretion in premenopausal women with seasonal affective disorder. Am J Psychiatry (1989) 1.40
[Patients with panic disorder: a 5-year follow-up study]. Acta Psiquiatr Psicol Am Lat (1992) 1.37
Emergence delirium in adults in the post-anaesthesia care unit. Br J Anaesth (2006) 1.33
The mode selection trial (MOST) in sinus node dysfunction: design, rationale, and baseline characteristics of the first 1000 patients. Am Heart J (2000) 1.33
Importance of psychotic features to long-term course in major depressive disorder. Am J Psychiatry (1996) 1.33
A proposed autacoid mechanism controlling mastocyte behaviour. Agents Actions (1993) 1.32
A randomized, prospective comparison of anterior and posterior approaches to radiofrequency catheter ablation of atrioventricular nodal reentry tachycardia. Circulation (1993) 1.28
Pharmacological effects of phosphatidylserine liposomes. Nature (1976) 1.22
An integrated restriction fragment length polymorphism--amplified fragment length polymorphism linkage map for cultivated sunflower. Genome (2001) 1.19
Association between glycoconjugate antibodies and Campylobacter infection in patients with Guillain-Barré syndrome. J Neuroimmunol (1991) 1.19
Voltage-dependent activation and inactivation of calcium channels in PC12 cells. Correlation with neurotransmitter release. J Biol Chem (1987) 1.19
Nerve growth factor activates Thy-1 and neurofilament gene transcription in rat PC12 cells. EMBO J (1986) 1.19
Recurrence of conduction in accessory atrioventricular connections after initially successful radiofrequency catheter ablation. J Am Coll Cardiol (1992) 1.19
Dopamine and the structure of personality: relation of agonist-induced dopamine activity to positive emotionality. J Pers Soc Psychol (1994) 1.18
Direct interaction of proliferating cell nuclear antigen with the p125 catalytic subunit of mammalian DNA polymerase delta. J Biol Chem (1999) 1.17
Interaction between nerve growth factor and lysophosphatidylserine on rat peritoneal mast cells. FEBS Lett (1982) 1.16
Incidence and implications of abrasion of implantable cardioverter-defibrillator leads. Am J Cardiol (1997) 1.12
A pilot newborn screening for congenital adrenal hyperplasia in Alaska. J Clin Endocrinol Metab (1982) 1.10
Pharmacological effects of phosphatidylserine liposomes: the role of lysophosphatidylserine. Br J Pharmacol (1979) 1.09
Quercetin protects cutaneous tissue-associated cell types including sensory neurons from oxidative stress induced by glutathione depletion: cooperative effects of ascorbic acid. Free Radic Biol Med (1997) 1.06
Facilitation of working memory in humans by a d2 dopamine receptor agonist. J Cogn Neurosci (1992) 1.05
An early-onset retinal dystrophy with dominant inheritance in the Abyssinian cat. Clinical and pathological findings. Invest Ophthalmol Vis Sci (1987) 1.05
Basic fibroblast growth factor promotes the survival and development of mesencephalic neurons in culture. Dev Biol (1989) 1.02
Update of the NGF saga. J Neurol Sci (1995) 1.00
Peripheral levels of BDNF and NGF in primary headaches. Cephalalgia (2006) 0.98
Evidence that DNA polymerase delta isolated by immunoaffinity chromatography exhibits high-molecular weight characteristics and is associated with the KIAA0039 protein and RPA. Biochemistry (2000) 0.97
Pharmacological effects of phosphatidylserine liposomes: regulation of gylcolysis and energy level in brain. Br J Pharmacol (1979) 0.97
The tumour associated antigen CA15.3 in primary breast cancer. Evaluation of 667 cases. Br J Cancer (1991) 0.96
Dynamic light scattering from lyotropic lamellar phases subjected to a flow field. Phys Rev E Stat Nonlin Soft Matter Phys (2001) 0.95
Design, recruitment, logistics, and data management of the GEHA (Genetics of Healthy Ageing) project. Exp Gerontol (2011) 0.95
Nerve growth factor and autoimmune diseases. Autoimmunity (1994) 0.94
Aspirin prevention of NMDA-induced neuronal death by direct protein kinase Czeta inhibition. J Neurochem (2005) 0.94
Use of Fourier-transform infrared spectroscopy for typing of Candida albicans strains isolated in intensive care units. J Clin Microbiol (2003) 0.93
Relationship of neuronal vulnerability and calcium binding protein immunoreactivity in ischemia. Exp Brain Res (1990) 0.93
Low-volume nodal metastases detected at retroperitoneal lymphadenectomy for testicular cancer: pattern and prognostic factors for relapse. J Clin Oncol (2001) 0.92
A saturated N-acylethanolamine other than N-palmitoyl ethanolamine with anti-inflammatory properties: a neglected story... J Neuroendocrinol (2008) 0.92
Lack of superiority of steroids plus plasma exchange to steroids alone in the treatment of polyarteritis nodosa and Churg-Strauss syndrome. A prospective, randomized trial in 78 patients. Arthritis Rheum (1992) 0.92
Promotion of neuritogenesis in mouse neuroblastoma cells by exogenous gangliosides. Relationship between the effect and the cell association of ganglioside GM1. J Neurochem (1984) 0.91
Treatment of polyarteritis nodosa related to hepatitis B virus with short term steroid therapy associated with antiviral agents and plasma exchanges. A prospective trial in 33 patients. J Rheumatol (1993) 0.91
Overexpression of fra-2 in transgenic mice perturbs normal eye development. Oncogene (1998) 0.90
Effect of brain cortex phospholipids on adenylate-cyclase activity of mouse brain. J Neurochem (1978) 0.90
Are myeloma patients with renal failure candidates for autologous stem cell transplantation? Hematol J (2000) 0.90
Biochemistry of primary headaches: role of tyrosine and tryptophan metabolism. Neurol Sci (2015) 0.90
Evidence for a physiological role of nerve growth factor in the central nervous system of neonatal rats. Neuron (1989) 0.89
A developmentally regulated switch in neuronal responsiveness to NCAM and N-cadherin in the rat hippocampus. Development (1992) 0.89
Characteristics and significance of untreated major depressive disorder. Am J Psychiatry (1995) 0.88
Nerve growth factor in the anterior pituitary: localization in mammotroph cells and cosecretion with prolactin by a dopamine-regulated mechanism. Proc Natl Acad Sci U S A (1996) 0.88
Simultaneous recording of local electrical activity, partial oxygen tension and temperature in the rat hippocampus with a chamber-type microelectrode. Effects of anaesthesia, ischemia and epilepsy. Neuroscience (1989) 0.88
A family study of manic-depressive (bipolar I) disease. Is it a distinct illness separable from primary unipolar depression? Arch Gen Psychiatry (1995) 0.88
Autologous stem-cell transplantation in diffuse large B-cell non-Hodgkin's lymphoma not achieving complete response after induction chemotherapy: the GEL/TAMO experience. Ann Oncol (2004) 0.87
Effect of polar lipids on cerebral content of free glucose in mice. Adv Exp Med Biol (1976) 0.87
Ganglioside GM1 prevents death induced by excessive excitatory neurotransmission in cultured hippocampal pyramidal neurons. Neurosci Lett (1991) 0.87
Excitatory amino acid-induced alterations of cytoplasmic free Ca2+ in individual cerebellar granule neurons: role in neurotoxicity. J Neurosci Res (1991) 0.86
Choline acetyltransferase messenger RNA expression in developing and adult rat brain: regulation by nerve growth factor. Brain Res Mol Brain Res (1991) 0.86
Technetium-99m as a label for erythrocytes. J Nucl Med (1967) 0.86
Immediate type 1 hypersensitivity to apomorphine: a case report. J Investig Allergol Clin Immunol (2011) 0.86
Inflammatory mediator stimulation of astrocytes and meningeal fibroblasts induces neuronal degeneration via the nitridergic pathway. J Neurochem (1995) 0.86
Alcoholism and drug abuse in three groups--bipolar I, unipolars and their acquaintances. J Affect Disord (1998) 0.86
Does major depressive disorder change with age? Psychol Med (2009) 0.85
Autologous peripheral blood stem cell transplantation for multiple myeloma: a report of 259 cases from the Spanish Registry. Spanish Registry for Transplant in MM (Grupo Español de Trasplante Hematopoyético-GETH) and PETHEMA. Bone Marrow Transplant (1998) 0.85
Hippocampal cell death following ischemia: effects of brain temperature and anesthesia. Exp Neurol (1990) 0.84
Modification of noradrenergic hypothalamic system in rat injected with phosphatidylserine liposomes. Life Sci (1978) 0.84
Elusive amines and primary headaches: historical background and prospectives. Neurol Sci (2003) 0.82
Monosialogangliosides and their action in modulating neuroplastic behaviors of neuronal cells. Adv Exp Med Biol (1990) 0.82
Determinants of impedance during radiofrequency catheter ablation in humans. Am J Cardiol (1992) 0.82
Ganglioside function in the development and repair of the nervous system. From basic science to clinical application. Mol Neurobiol (1989) 0.82
A role for gangliosides in astroglial cell differentiation in vitro. J Cell Biol (1988) 0.82
In vivo activated brain astrocytes may produce and secrete nerve growth factor-like molecules. Neurochem Int (1992) 0.82
Effect of the atrioventricular relationship on atrial refractoriness in humans. Pacing Clin Electrophysiol (1992) 0.82
Comparison of the cost of radiofrequency catheter modification of the atrioventricular node and medical therapy for drug-refractory atrioventricular node reentrant tachycardia. J Am Coll Cardiol (1992) 0.81
N-acetylaspartylglutamate selectively inhibits neuronal responses to N-methyl-D-aspartic acid in vitro. J Neurochem (1994) 0.81
Disturbances of affect expression in failure-to-thrive. J Am Acad Child Adolesc Psychiatry (1991) 0.81
Human immunodeficiency virus type 1 envelope glycoprotein gp120 induces tumor necrosis factor-alpha in astrocytes. J NeuroAIDS (1999) 0.81
Nerve growth factor transcriptional control of c-fos promoter transfected in cultured spinal sensory neurons. J Cell Biol (1992) 0.81
Persistence of depressive symptoms and cardiovascular death among patients with affective disorder. Psychosom Med (2000) 0.81
Parkinsonian serum carries complement-dependent toxicity for rat mesencephalic dopaminergic neurons in culture. Brain Res (1994) 0.81
H(2)O(2) induces upregulation of Fas and Fas ligand expression in NGF-differentiated PC12 cells: modulation by cAMP. J Neurosci Res (2002) 0.81
Mast cell activation causes delayed neurodegeneration in mixed hippocampal cultures via the nitric oxide pathway. J Neurochem (1996) 0.81
Effect of brain cortex phospholipids on catechol-amine content of mouse brain. Pharmacol Res Commun (1976) 0.81
Dorsal root ganglia and nerve growth factor: a model for understanding the mechanism of GM1 effects on neuronal repair. J Neurosci Res (1984) 0.80
The effects of plasmapheresis on thyroid hormone and plasma drug concentrations in amiodarone-induced thyrotoxicosis. Br J Clin Pharmacol (1991) 0.80
Differences in induction of c-fos transcription by cholera toxin-derived cyclic AMP and Ca2+ signals in astrocytes and 3T3 fibroblasts. Exp Cell Res (1991) 0.80
Extracorporeal photochemotherapy: evaluation of two techniques and use in connective tissue disorders. Transfus Sci (1994) 0.80
Death of cultured hippocampal pyramidal neurons induced by pathological activation of N-methyl-D-aspartate receptors is reduced by monosialogangliosides. J Pharmacol Exp Ther (1991) 0.80
Diclofenac, paracetamol, and vidarabine removal during plasma exchange in polyarteritis nodosa patients. Biopharm Drug Dispos (1991) 0.80
Is tissue polypeptide antigen still a useful tumor marker in breast carcinoma? Comparison with CA15.3 and MCA. Tumori (1990) 0.79
Protective effects of a monosialoganglioside derivative following transitory forebrain ischemia in rats. Stroke (1990) 0.79
Ganglioside modulation of neural cell adhesion molecule and N-cadherin-dependent neurite outgrowth. J Cell Biol (1992) 0.79
GM1 ganglioside potentiates the effect of nerve growth factor in preventing vinblastine-induced sympathectomy in newborn rats. Brain Res (1988) 0.78